Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

Innovative antipsychotic ADASUVE® to benefit even more patients

27. 5. 2015

Homozygous Familial Hypercholesterolaemia

30. 4. 2015

AOP Orphan and Rigi Healthcare start Rigi Orphan Inc., USA

8. 4. 2015

Confluence Pharmaceuticals Signs Co-Development and Marketing Agreement with AOP Health for Fragile X Syndrome Drug

23. 3. 2015

AOP Orphan Pharmaceuticals announces progress of pivotal phase III trial PROUD-PV applying Ropeginterferon alfa 2b, a novel, long-acting, mono-pegylated Interferon for treatment of Polycythemia Vera

5. 3. 2015

AOP Orphan to be commercialization partner for Canadian pharmaceutical specialist Cardiome

10. 12. 2014